- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Anaplastic Lymphoma Kinase Rearrangement
Total 19066 results
-
Atara BiotherapeuticsRecruitingHigh-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditionsUnited States
-
Massachusetts General HospitalPfizer; Array BioPharmaRecruitingNSCLC | Lung Cancer | Relapsed Cancer | Resistant Cancer | MET Amplification | Anaplastic Lymphoma Kinase Gene Translocation | ROS1 RearrangementUnited States
-
Hoffmann-La RocheActive, not recruitingMelanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditionsUnited States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland
-
Hoffmann-La RocheTerminatedDigestive System Diseases | Gastrointestinal Diseases | Melanoma | Sarcoma | Neoplasms | Respiratory Tract Diseases | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasms | Head and Neck Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms and other conditionsUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase Gene MutationFrance
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Xcovery Holding Company, LLCAvailableNon-Small Cell Lung Cancer | ALK Gene Rearrangement PositiveUnited States
-
Jun ZhuPeking University First Hospital; Peking University People's Hospital; Peking... and other collaboratorsWithdrawnSystemic Anaplastic Large-Cell LymphomaChina
-
7 Hills Pharma, LLCRecruitingMelanoma | Kidney Cancer | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | NSCLC | Non Small Cell Lung Cancer | Skin Cancer | Metastasis | Advanced Solid Tumor | Advanced Cancer | Renal Cell Cancer | Hepatocellular Cancer | Mismatch Repair Deficiency | Pleural Mesothelioma | MSI-High | Anaplastic Lymphoma... and other conditionsUnited States
-
Shouyao Holdings (Beijing) Co. LTDNot yet recruitingNon-small Cell Lung CancerChina
-
University of Milano BicoccaRecruiting
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Taiwan, United States, Australia, Israel, Hong Kong, Chile, Korea, Republic of, Canada, Malaysia, Thailand
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
Shouyao Holdings (Beijing) Co. LTDRecruitingNon-small-cell Lung CarcinomaChina
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingNeoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Neoplasms by Site | Renal Cell Carcinoma | Cancer | Solid Tumor | Anaplastic Large Cell Lymphoma | Neuroblastoma | Malignant Neoplasm | Haematological MalignancyUnited Kingdom
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)China
-
University Medical Center GroningenRadboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaboratorsRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Drug Monitoring | Anaplastic Lymphoma Kinase Gene Mutation | Anaplastic Lymphoma Kinase Gene TranslocationNetherlands, France
-
Peking Union Medical College HospitalBetta Pharmaceuticals Co., Ltd.RecruitingCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma Kinase I1171N | EnsartinibChina
-
Betta Pharmaceuticals Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
Shandong Provincial HospitalRecruitingMantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsChina
-
PfizerRecruitingNSCLC | IMT | ALCLChina, Taiwan, Japan, Russian Federation, Italy
-
PfizerRecruitingNSCLC | Non-Small-Cell Lung CancerSpain, China, Taiwan, France, Singapore, Japan, United States
-
Massachusetts General HospitalLUNGevity Foundation; Addario Lung Cancer Medical InstituteRecruitingNon-Small Cell Lung Cancer | Anaplastic Lymphoma Kinase Gene TranslocationUnited States
-
Jacob Soumerai, MDGlaxoSmithKlineRecruitingRelapsed Plasmablastic Lymphoma | Refractory Plasmablastic Lymphoma | Anaplastic Lymphoma Kinase Positive Large B-Cell LymphomaUnited States
-
TakedaRecruitingCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseKorea, Republic of
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
Hoffmann-La RocheRecruitingNeoplasmsItaly, France, Turkey, Korea, Republic of, Spain, China, United States, Hong Kong, Russian Federation, Poland
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Canada, Taiwan, Australia, France, Hong Kong, Italy, Portugal, Spain, United Kingdom, Brazil, Poland, Guatemala, Singapore, Thailand, Serbia, Ukraine, Bosnia and Herzegovina, China, Costa Rica, E... and more
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung CancerUnited States
-
TakedaCompletedALK-positive Advanced NSCLCJapan
-
PfizerActive, not recruiting
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell LymphomaUnited States
-
Hoffmann-La RocheActive, not recruitingAnaplastic Lymphoma Kinase-positive Non-small Cell Lung CancerChina, Korea, Republic of, Thailand
-
Hoffmann-La RocheActive, not recruitingSolid Tumors | CNS TumorsUnited States, Spain, Korea, Republic of, Canada, Germany, United Kingdom, China, Italy, Hong Kong, France, Taiwan
-
Regeneron PharmaceuticalsActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
PfizerActive, not recruitingCarcinoma, Non-Small-Cell LungCanada, Spain, United States, China, Korea, Republic of, United Kingdom, France, Czechia, Japan, Singapore, Taiwan, Australia, Netherlands, India, Turkey, Hong Kong, Argentina, Belgium, Germany, Italy, Mexico, Poland, Russian Federation
-
European Organisation for Research and Treatment...Active, not recruitingNon Small Cell Lung CancerNetherlands, Spain, France, United Kingdom, Norway, Jordan, Belgium
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Childhood Solid Neoplasm | Recurrent Childhood Anaplastic Large Cell LymphomaUnited States, Canada
-
SCRI Development Innovations, LLCPfizerWithdrawnLung Cancer | Non-small Cell Lung CancerUnited States
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
TakedaCompletedCarcinoma Non-small-cell Lung | Anaplastic Lymphoma Kinase-positiveUnited States
-
PfizerTerminatedNeoplasms MalignantUnited States, Korea, Republic of, Japan, China, Taiwan, Italy, Russian Federation
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedSarcoma | Lymphoma | Kidney Cancer | Unspecified Childhood Solid Tumor, Protocol Specific | Testicular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
TakedaCompletedCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseArgentina
-
PfizerCompletedNon-Small-Cell Lung CarcinomaUnited States
-
University of Milano BicoccaCompletedAnaplastic Large Cell Lymphoma, ALK-PositiveItaly